Trial intelligence / Profile preview

Intravenous ketorolac versus ibuprofen for acute low back pain in the emergency department

IRCT20151113025025N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in acute lumbago comparing Intravenous ibuprofen with Intravenous ketorolac (2 arms). Primary endpoints: Pain score and Adverse effects. Started Jun 2020; status: completed.

02

Drugs

ketorolacibuprofen
03

Conditions

acute lumbago

Beyond the preview

Go deeper on IRCT20151113025025N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151113025025N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call